(Q35785106)

10 August 2017

1 reference

title

Desferoxamine (DFO)--mediated iron chelation: rationale for a novel approach to therapy for brain cancer (English)

1 reference

10 August 2017

0 references

1 reference

Pouya N Dayani

1

1 reference

10 August 2017

Maria C Bishop

series ordinal

2

1 reference

10 August 2017

Keith Black

series ordinal

3

1 reference

10 August 2017

Paul M Zeltzer

series ordinal

4

1 reference

10 August 2017

publication date

1 May 2004

1 reference

Journal of Neuro-Oncology

10 August 2017

published in

1 reference

10 August 2017

volume

67

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

367-377

1 reference

https://scigraph.springernature.com/pub.10.1023/b:neon.0000024238.21349.37

10 August 2017

exact match

0 references

cites work

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

1 reference

12 December 2020

Up-regulation of vascular endothelial growth factor production by iron chelators

1 reference

12 December 2020

Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy

1 reference

12 December 2020

D-CECaT as preoperative chemotherapy for unresectable neuroblastoma in children over one year of age

1 reference

12 December 2020

Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells

1 reference

12 December 2020

Conservation of ferritin heavy subunit gene structure: implications for the regulation of ferritin gene expression

1 reference

12 December 2020

Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron-Loaded Subjects

1 reference

12 December 2020

Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs

1 reference

12 December 2020

Screening of transcriptionally regulated genes following iron chelation in human astrocytoma cells

1 reference

12 December 2020

Potential of iron chelators as effective antiproliferative agents

1 reference

12 December 2020

Iron-chelating agents in non-iron overload conditions

1 reference

12 December 2020

Roles of iron in neoplasia. Promotion, prevention, and therapy

1 reference

12 December 2020

Transcriptional regulation of the tartrate-resistant acid phosphatase (TRAP) gene by iron

1 reference

12 December 2020

Deferoxamine inhibition of human neuroblastoma viability and proliferation

1 reference

12 December 2020

The long 3'-untranslated regions of the PDGF-A and -B mRNAs are only distantly related

1 reference

12 December 2020

The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells

1 reference

12 December 2020

Deferoxamine, cyclophosphamide, etoposide, carboplatin, and thiotepa (D-CECaT): a new cytoreductive chelation-chemotherapy regimen in patients with advanced neuroblastoma

1 reference

12 December 2020

Effects of a single course of deferoxamine in neuroblastoma patients

1 reference

12 December 2020

Regulation of protein kinase C (PKC) expression by iron: effect of different iron compounds on PKC-beta and PKC-alpha gene expression and role of the 5'-flanking region of the PKC-beta gene in the response to ferric transferrin.

1 reference

12 December 2020

THE BIOCHEMISTRY OF DESFERRIOXAMINE AND ITS RELATION TO IRON METABOLISM

1 reference

12 December 2020

Brain iron: location and function

1 reference

12 December 2020

The mechanisms of iron uptake by fetal rat hepatocytes in culture

1 reference

12 December 2020

The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis

1 reference

12 December 2020

Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle

1 reference

12 December 2020

Cloning and characterization of the human tartrate-resistant acid phosphatase (TRAP) gene.

1 reference

12 December 2020

The sequences of human and bovine genes of the phosphate carrier from mitochondria contain evidence of alternatively spliced forms

1 reference

12 December 2020

The uptake of iron and transferrin by the human malignant melanoma cell

1 reference

12 December 2020

Iron regulates nitric oxide synthase activity by controlling nuclear transcription

1 reference

12 December 2020

Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: preliminary results. Italian Neuroblastoma Cooperative Group

1 reference

12 December 2020

Iron in brain function and dysfunction with emphasis on Parkinson's disease

1 reference

12 December 2020

Iron-induced carcinogenesis: the role of redox regulation

1 reference

12 December 2020

Hypoxic induction of vascular endothelial growth factor (VEGF) protein in astroglial cultures.

1 reference

12 December 2020

Induction of protein kinase C mRNA in cultured lymphoblastoid T cells by iron-transferrin but not by soluble iron

1 reference

12 December 2020

Deferoxamine-induced cytotoxicity in human neuronal cell lines: protection by free radical scavengers

1 reference

12 December 2020

Antineuroblastoma activity of desferoxamine in human cell lines

1 reference

12 December 2020

In vitro and in vivo effects of deferoxamine in neonatal acute leukemia

1 reference

12 December 2020

Reduction of Ribonucleotides

1 reference

12 December 2020

Hypoxia-induced vascular endothelial growth factor expression in normal rat astrocyte cultures

1 reference

12 December 2020

Effects of positive iron status at a cellular level.

1 reference

12 December 2020

Effect of different exposures to desferrioxamine on neuroblastoma cell lines

1 reference

12 December 2020

Two saturable mechanisms of iron uptake from transferrin in human melanoma cells: the effect of transferrin concentration, chelators, and metabolic probes on transferrin and iron uptake

1 reference

12 December 2020

New perspectives on iron: an introduction

1 reference

12 December 2020

Organization and sequence of the human gene encoding cytokeratin 8

1 reference

12 December 2020

Deferoxamine in children with recurrent neuroblastoma

1 reference

12 December 2020

Transcriptional regulation by iron of the gene for the transferrin receptor

1 reference

12 December 2020

Cell cycle-dependent inhibition of the proliferation of human neural tumor cell lines by iron chelators.

1 reference

12 December 2020

DIFFERENTIAL FERRIOXAMINE TEST FOR MEASURING CHELATABLE BODY IRON.

1 reference

12 December 2020

The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents

1 reference

12 December 2020

Induction of ferritin subunit synthesis by iron is regulated at both the transcriptional and translational levels

1 reference

12 December 2020

The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydra

1 reference

12 December 2020

Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice

1 reference

12 December 2020

Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators

1 reference

12 December 2020

Effects of agents that inhibit cellular iron incorporation on bladder cancer cell proliferation.

1 reference

12 December 2020

Failure of iron chelators to reduce tumor growth in human neuroblastoma xenografts

1 reference

12 December 2020

Role of deferoxamine in tumor therapy

1 reference

12 December 2020

Antileukemic effects of deferoxamine on human myeloid leukemia cell lines

1 reference

12 December 2020

Regulation and drug resistance mechanisms of mammalian ribonucleotide reductase, and the significance to DNA synthesis.

1 reference

12 December 2020

Results of long-term iron-chelating therapy

1 reference

12 December 2020

10.1023/B:NEON.0000024238.21349.37

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

1035776680

0 references

1 reference